Global Psoriasis Drugs Sales Market Report 2018

June 2018 | 101 pages | ID: G52389E982CEN
QYResearch

Abstracts

This report studies the global Psoriasis Drugs market status and forecast, categorizes the global Psoriasis Drugs market size (value & volume) by key players, type, application, and region.
This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).
Psoriasis is a long-lasting autoimmune disease characterized by patches of abnormal skin. These skin patches are typically red, itchy, and scaly. Psoriasis varies in severity from small, localized patches to complete body coverage.

The global Psoriasis Drugs market is valued at 12600 million US$ in 2017 and will reach 25600 million US$ by the end of 2025, growing at a CAGR of 9.3% during 2018-2025.
The major players covered in this report

• AbbVie
• Amgen
• Johnson & Johnson
• Novartis
• Eli Lilly
• AstraZeneca
• Celgene

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

• United States
• Europe
• China
• Japan
• Southeast Asia
• India

We can also provide the customized separate regional or country-level reports, for the following regions:

• North America
• United States
• Canada
• Mexico
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Singapore
• Rest of Asia-Pacific
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Russia
• Rest of Europe
• Central & South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Saudi Arabia
• Turkey
• Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• TNF-inhibitors
• Interleukin-inhibitors
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Clinic

The study objectives of this report are:

• To analyze and study the global Psoriasis Drugs sales, value, status (2013-2017) and forecast (2018-2025);
• To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
• Focuses on the key Psoriasis Drugs players, to study the sales, value, market share and development plans in future.
• Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
• To define, describe and forecast the market by type, application and region.
• To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
• To identify significant trends and factors driving or inhibiting the market growth.
• To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
• To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
• To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Psoriasis Drugs are as follows:

• History Year: 2013-2017
• Base Year: 2017
• Estimated Year: 2018
• Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Psoriasis Drugs Manufacturers
Psoriasis Drugs Distributors/Traders/Wholesalers
Psoriasis Drugs Subcomponent Manufacturers
Industry Association
Downstream Vendors
Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Psoriasis Drugs market, by end-use.
Detailed analysis and profiles of additional market players.

Contents

Global Psoriasis Drugs Sales Market Report 2018

1 PSORIASIS DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Psoriasis Drugs
1.2 Classification of Psoriasis Drugs by Product Category
  1.2.1 Global Psoriasis Drugs Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 Global Psoriasis Drugs Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 TNF-inhibitors
  1.2.4 Interleukin-inhibitors
  1.2.5 Others
1.3 Global Psoriasis Drugs Market by Application/End Users
  1.3.1 Global Psoriasis Drugs Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.1 Hospital
  1.3.2 Clinic
1.4 Global Psoriasis Drugs Market by Region
  1.4.1 Global Psoriasis Drugs Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 United States Psoriasis Drugs Status and Prospect (2013-2025)
  1.4.3 Europe Psoriasis Drugs Status and Prospect (2013-2025)
  1.4.4 China Psoriasis Drugs Status and Prospect (2013-2025)
  1.4.5 Japan Psoriasis Drugs Status and Prospect (2013-2025)
  1.4.6 Southeast Asia Psoriasis Drugs Status and Prospect (2013-2025)
  1.4.7 India Psoriasis Drugs Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Psoriasis Drugs (2013-2025)
  1.5.1 Global Psoriasis Drugs Sales and Growth Rate (2013-2025)
  1.5.2 Global Psoriasis Drugs Revenue and Growth Rate (2013-2025)

2 GLOBAL PSORIASIS DRUGS COMPETITION BY PLAYERS/SUPPLIERS, TYPE AND APPLICATION

2.1 Global Psoriasis Drugs Market Competition by Players/Suppliers
  2.1.1 Global Psoriasis Drugs Sales and Market Share of Key Players/Suppliers (2013-2018)
  2.1.2 Global Psoriasis Drugs Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Psoriasis Drugs (Volume and Value) by Type
  2.2.1 Global Psoriasis Drugs Sales and Market Share by Type (2013-2018)
  2.2.2 Global Psoriasis Drugs Revenue and Market Share by Type (2013-2018)
2.3 Global Psoriasis Drugs (Volume and Value) by Region
  2.3.1 Global Psoriasis Drugs Sales and Market Share by Region (2013-2018)
  2.3.2 Global Psoriasis Drugs Revenue and Market Share by Region (2013-2018)
2.4 Global Psoriasis Drugs (Volume) by Application

3 UNITED STATES PSORIASIS DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 United States Psoriasis Drugs Sales and Value (2013-2018)
  3.1.1 United States Psoriasis Drugs Sales and Growth Rate (2013-2018)
  3.1.2 United States Psoriasis Drugs Revenue and Growth Rate (2013-2018)
  3.1.3 United States Psoriasis Drugs Sales Price Trend (2013-2018)
3.2 United States Psoriasis Drugs Sales Volume and Market Share by Players (2013-2018)
3.3 United States Psoriasis Drugs Sales Volume and Market Share by Type (2013-2018)
3.4 United States Psoriasis Drugs Sales Volume and Market Share by Application (2013-2018)

4 EUROPE PSORIASIS DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 Europe Psoriasis Drugs Sales and Value (2013-2018)
  4.1.1 Europe Psoriasis Drugs Sales and Growth Rate (2013-2018)
  4.1.2 Europe Psoriasis Drugs Revenue and Growth Rate (2013-2018)
  4.1.3 Europe Psoriasis Drugs Sales Price Trend (2013-2018)
4.2 Europe Psoriasis Drugs Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Psoriasis Drugs Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Psoriasis Drugs Sales Volume and Market Share by Application (2013-2018)

5 CHINA PSORIASIS DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 China Psoriasis Drugs Sales and Value (2013-2018)
  5.1.1 China Psoriasis Drugs Sales and Growth Rate (2013-2018)
  5.1.2 China Psoriasis Drugs Revenue and Growth Rate (2013-2018)
  5.1.3 China Psoriasis Drugs Sales Price Trend (2013-2018)
5.2 China Psoriasis Drugs Sales Volume and Market Share by Players (2013-2018)
5.3 China Psoriasis Drugs Sales Volume and Market Share by Type (2013-2018)
5.4 China Psoriasis Drugs Sales Volume and Market Share by Application (2013-2018)

6 JAPAN PSORIASIS DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Psoriasis Drugs Sales and Value (2013-2018)
  6.1.1 Japan Psoriasis Drugs Sales and Growth Rate (2013-2018)
  6.1.2 Japan Psoriasis Drugs Revenue and Growth Rate (2013-2018)
  6.1.3 Japan Psoriasis Drugs Sales Price Trend (2013-2018)
6.2 Japan Psoriasis Drugs Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Psoriasis Drugs Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Psoriasis Drugs Sales Volume and Market Share by Application (2013-2018)

7 SOUTHEAST ASIA PSORIASIS DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Psoriasis Drugs Sales and Value (2013-2018)
  7.1.1 Southeast Asia Psoriasis Drugs Sales and Growth Rate (2013-2018)
  7.1.2 Southeast Asia Psoriasis Drugs Revenue and Growth Rate (2013-2018)
  7.1.3 Southeast Asia Psoriasis Drugs Sales Price Trend (2013-2018)
7.2 Southeast Asia Psoriasis Drugs Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Psoriasis Drugs Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Psoriasis Drugs Sales Volume and Market Share by Application (2013-2018)

8 INDIA PSORIASIS DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 India Psoriasis Drugs Sales and Value (2013-2018)
  8.1.1 India Psoriasis Drugs Sales and Growth Rate (2013-2018)
  8.1.2 India Psoriasis Drugs Revenue and Growth Rate (2013-2018)
  8.1.3 India Psoriasis Drugs Sales Price Trend (2013-2018)
8.2 India Psoriasis Drugs Sales Volume and Market Share by Players (2013-2018)
8.3 India Psoriasis Drugs Sales Volume and Market Share by Type (2013-2018)
8.4 India Psoriasis Drugs Sales Volume and Market Share by Application (2013-2018)

9 GLOBAL PSORIASIS DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

9.1 AbbVie
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Psoriasis Drugs Product Category, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 AbbVie Psoriasis Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  9.1.4 Main Business/Business Overview
9.2 Amgen
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Psoriasis Drugs Product Category, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 Amgen Psoriasis Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  9.2.4 Main Business/Business Overview
9.3 Johnson & Johnson
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Psoriasis Drugs Product Category, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 Johnson & Johnson Psoriasis Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  9.3.4 Main Business/Business Overview
9.4 Novartis
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Psoriasis Drugs Product Category, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 Novartis Psoriasis Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  9.4.4 Main Business/Business Overview
9.5 Eli Lilly
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Psoriasis Drugs Product Category, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 Eli Lilly Psoriasis Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  9.5.4 Main Business/Business Overview
9.6 AstraZeneca
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Psoriasis Drugs Product Category, Application and Specification
    9.6.2.1 Product A
    9.6.2.2 Product B
  9.6.3 AstraZeneca Psoriasis Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  9.6.4 Main Business/Business Overview
9.7 Celgene
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Psoriasis Drugs Product Category, Application and Specification
    9.7.2.1 Product A
    9.7.2.2 Product B
  9.7.3 Celgene Psoriasis Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  9.7.4 Main Business/Business Overview

10 PSORIASIS DRUGS MAUFACTURING COST ANALYSIS

10.1 Psoriasis Drugs Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Psoriasis Drugs
10.3 Manufacturing Process Analysis of Psoriasis Drugs

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Psoriasis Drugs Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Psoriasis Drugs Major Manufacturers in 2017
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL PSORIASIS DRUGS MARKET FORECAST (2018-2025)

14.1 Global Psoriasis Drugs Sales Volume, Revenue and Price Forecast (2018-2025)
  14.1.1 Global Psoriasis Drugs Sales Volume and Growth Rate Forecast (2018-2025)
  14.1.2 Global Psoriasis Drugs Revenue and Growth Rate Forecast (2018-2025)
  14.1.3 Global Psoriasis Drugs Price and Trend Forecast (2018-2025)
14.2 Global Psoriasis Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
  14.2.1 Global Psoriasis Drugs Sales Volume and Growth Rate Forecast by Regions (2018-2025)
  14.2.2 Global Psoriasis Drugs Revenue and Growth Rate Forecast by Regions (2018-2025)
  14.2.3 United States Psoriasis Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.4 Europe Psoriasis Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.5 China Psoriasis Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.6 Japan Psoriasis Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.7 Southeast Asia Psoriasis Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.8 India Psoriasis Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Psoriasis Drugs Sales Volume, Revenue and Price Forecast by Type (2018-2025)
  14.3.1 Global Psoriasis Drugs Sales Forecast by Type (2018-2025)
  14.3.2 Global Psoriasis Drugs Revenue Forecast by Type (2018-2025)
  14.3.3 Global Psoriasis Drugs Price Forecast by Type (2018-2025)
14.4 Global Psoriasis Drugs Sales Volume Forecast by Application (2018-2025)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Psoriasis Drugs
Figure Global Psoriasis Drugs Sales Volume Comparison (K Units) by Type (2013-2025)
Figure Global Psoriasis Drugs Sales Volume Market Share by Type (Product Category) in 2017
Figure TNF-inhibitors Product Picture
Figure Interleukin-inhibitors Product Picture
Figure Others Product Picture
Figure Global Psoriasis Drugs Sales Comparison (K Units) by Application (2013-2025)
Figure Global Sales Market Share of Psoriasis Drugs by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Global Psoriasis Drugs Market Size (Million USD) by Regions (2013-2025)
Figure United States Psoriasis Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Psoriasis Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Psoriasis Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Psoriasis Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Psoriasis Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Psoriasis Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Psoriasis Drugs Sales Volume (K Units) and Growth Rate (2013-2025)
Figure Global Psoriasis Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Psoriasis Drugs Sales Volume (K Units) (2013-2018)
Table Global Psoriasis Drugs Sales (K Units) of Key Players/Suppliers (2013-2018)
Table Global Psoriasis Drugs Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Psoriasis Drugs Sales Share by Players/Suppliers
Figure 2017 Psoriasis Drugs Sales Share by Players/Suppliers
Figure Global Psoriasis Drugs Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Psoriasis Drugs Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Psoriasis Drugs Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Psoriasis Drugs Revenue Share by Players
Table 2017 Global Psoriasis Drugs Revenue Share by Players
Table Global Psoriasis Drugs Sales (K Units) and Market Share by Type (2013-2018)
Table Global Psoriasis Drugs Sales Share (K Units) by Type (2013-2018)
Figure Sales Market Share of Psoriasis Drugs by Type (2013-2018)
Figure Global Psoriasis Drugs Sales Growth Rate by Type (2013-2018)
Table Global Psoriasis Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Psoriasis Drugs Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Psoriasis Drugs by Type (2013-2018)
Figure Global Psoriasis Drugs Revenue Growth Rate by Type (2013-2018)
Table Global Psoriasis Drugs Sales Volume (K Units) and Market Share by Region (2013-2018)
Table Global Psoriasis Drugs Sales Share by Region (2013-2018)
Figure Sales Market Share of Psoriasis Drugs by Region (2013-2018)
Figure Global Psoriasis Drugs Sales Growth Rate by Region in 2017
Table Global Psoriasis Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Psoriasis Drugs Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Psoriasis Drugs by Region (2013-2018)
Figure Global Psoriasis Drugs Revenue Growth Rate by Region in 2017
Table Global Psoriasis Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Psoriasis Drugs Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Psoriasis Drugs by Region (2013-2018)
Figure Global Psoriasis Drugs Revenue Market Share by Region in 2017
Table Global Psoriasis Drugs Sales Volume (K Units) and Market Share by Application (2013-2018)
Table Global Psoriasis Drugs Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Psoriasis Drugs by Application (2013-2018)
Figure Global Psoriasis Drugs Sales Market Share by Application (2013-2018)
Figure United States Psoriasis Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure United States Psoriasis Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Psoriasis Drugs Sales Price (USD/Unit) Trend (2013-2018)
Table United States Psoriasis Drugs Sales Volume (K Units) by Players (2013-2018)
Table United States Psoriasis Drugs Sales Volume Market Share by Players (2013-2018)
Figure United States Psoriasis Drugs Sales Volume Market Share by Players in 2017
Table United States Psoriasis Drugs Sales Volume (K Units) by Type (2013-2018)
Table United States Psoriasis Drugs Sales Volume Market Share by Type (2013-2018)
Figure United States Psoriasis Drugs Sales Volume Market Share by Type in 2017
Table United States Psoriasis Drugs Sales Volume (K Units) by Application (2013-2018)
Table United States Psoriasis Drugs Sales Volume Market Share by Application (2013-2018)
Figure United States Psoriasis Drugs Sales Volume Market Share by Application in 2017
Figure Europe Psoriasis Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Europe Psoriasis Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Psoriasis Drugs Sales Price (USD/Unit) Trend (2013-2018)
Table Europe Psoriasis Drugs Sales Volume (K Units) by Players (2013-2018)
Table Europe Psoriasis Drugs Sales Volume Market Share by Players (2013-2018)
Figure Europe Psoriasis Drugs Sales Volume Market Share by Players in 2017
Table Europe Psoriasis Drugs Sales Volume (K Units) by Type (2013-2018)
Table Europe Psoriasis Drugs Sales Volume Market Share by Type (2013-2018)
Figure Europe Psoriasis Drugs Sales Volume Market Share by Type in 2017
Table Europe Psoriasis Drugs Sales Volume (K Units) by Application (2013-2018)
Table Europe Psoriasis Drugs Sales Volume Market Share by Application (2013-2018)
Figure Europe Psoriasis Drugs Sales Volume Market Share by Application in 2017
Figure China Psoriasis Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure China Psoriasis Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Psoriasis Drugs Sales Price (USD/Unit) Trend (2013-2018)
Table China Psoriasis Drugs Sales Volume (K Units) by Players (2013-2018)
Table China Psoriasis Drugs Sales Volume Market Share by Players (2013-2018)
Figure China Psoriasis Drugs Sales Volume Market Share by Players in 2017
Table China Psoriasis Drugs Sales Volume (K Units) by Type (2013-2018)
Table China Psoriasis Drugs Sales Volume Market Share by Type (2013-2018)
Figure China Psoriasis Drugs Sales Volume Market Share by Type in 2017
Table China Psoriasis Drugs Sales Volume (K Units) by Application (2013-2018)
Table China Psoriasis Drugs Sales Volume Market Share by Application (2013-2018)
Figure China Psoriasis Drugs Sales Volume Market Share by Application in 2017
Figure Japan Psoriasis Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Japan Psoriasis Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Psoriasis Drugs Sales Price (USD/Unit) Trend (2013-2018)
Table Japan Psoriasis Drugs Sales Volume (K Units) by Players (2013-2018)
Table Japan Psoriasis Drugs Sales Volume Market Share by Players (2013-2018)
Figure Japan Psoriasis Drugs Sales Volume Market Share by Players in 2017
Table Japan Psoriasis Drugs Sales Volume (K Units) by Type (2013-2018)
Table Japan Psoriasis Drugs Sales Volume Market Share by Type (2013-2018)
Figure Japan Psoriasis Drugs Sales Volume Market Share by Type in 2017
Table Japan Psoriasis Drugs Sales Volume (K Units) by Application (2013-2018)
Table Japan Psoriasis Drugs Sales Volume Market Share by Application (2013-2018)
Figure Japan Psoriasis Drugs Sales Volume Market Share by Application in 2017
Figure Southeast Asia Psoriasis Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Southeast Asia Psoriasis Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Psoriasis Drugs Sales Price (USD/Unit) Trend (2013-2018)
Table Southeast Asia Psoriasis Drugs Sales Volume (K Units) by Players (2013-2018)
Table Southeast Asia Psoriasis Drugs Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Psoriasis Drugs Sales Volume Market Share by Players in 2017
Table Southeast Asia Psoriasis Drugs Sales Volume (K Units) by Type (2013-2018)
Table Southeast Asia Psoriasis Drugs Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Psoriasis Drugs Sales Volume Market Share by Type in 2017
Table Southeast Asia Psoriasis Drugs Sales Volume (K Units) by Application (2013-2018)
Table Southeast Asia Psoriasis Drugs Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Psoriasis Drugs Sales Volume Market Share by Application in 2017
Figure India Psoriasis Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure India Psoriasis Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Psoriasis Drugs Sales Price (USD/Unit) Trend (2013-2018)
Table India Psoriasis Drugs Sales Volume (K Units) by Players (2013-2018)
Table India Psoriasis Drugs Sales Volume Market Share by Players (2013-2018)
Figure India Psoriasis Drugs Sales Volume Market Share by Players in 2017
Table India Psoriasis Drugs Sales Volume (K Units) by Type (2013-2018)
Table India Psoriasis Drugs Sales Volume Market Share by Type (2013-2018)
Figure India Psoriasis Drugs Sales Volume Market Share by Type in 2017
Table India Psoriasis Drugs Sales Volume (K Units) by Application (2013-2018)
Table India Psoriasis Drugs Sales Volume Market Share by Application (2013-2018)
Figure India Psoriasis Drugs Sales Volume Market Share by Application in 2017
Table AbbVie Basic Information List
Table AbbVie Psoriasis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AbbVie Psoriasis Drugs Sales Growth Rate (2013-2018)
Figure AbbVie Psoriasis Drugs Sales Global Market Share (2013-2018)
Figure AbbVie Psoriasis Drugs Revenue Global Market Share (2013-2018)
Table Amgen Basic Information List
Table Amgen Psoriasis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Amgen Psoriasis Drugs Sales Growth Rate (2013-2018)
Figure Amgen Psoriasis Drugs Sales Global Market Share (2013-2018)
Figure Amgen Psoriasis Drugs Revenue Global Market Share (2013-2018)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Psoriasis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Johnson & Johnson Psoriasis Drugs Sales Growth Rate (2013-2018)
Figure Johnson & Johnson Psoriasis Drugs Sales Global Market Share (2013-2018
Figure Johnson & Johnson Psoriasis Drugs Revenue Global Market Share (2013-2018)
Table Novartis Basic Information List
Table Novartis Psoriasis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis Psoriasis Drugs Sales Growth Rate (2013-2018)
Figure Novartis Psoriasis Drugs Sales Global Market Share (2013-2018)
Figure Novartis Psoriasis Drugs Revenue Global Market Share (2013-2018)
Table Eli Lilly Basic Information List
Table Eli Lilly Psoriasis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Eli Lilly Psoriasis Drugs Sales Growth Rate (2013-2018)
Figure Eli Lilly Psoriasis Drugs Sales Global Market Share (2013-2018)
Figure Eli Lilly Psoriasis Drugs Revenue Global Market Share (2013-2018)
Table AstraZeneca Basic Information List
Table AstraZeneca Psoriasis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AstraZeneca Psoriasis Drugs Sales Growth Rate (2013-2018)
Figure AstraZeneca Psoriasis Drugs Sales Global Market Share (2013-2018
Figure AstraZeneca Psoriasis Drugs Revenue Global Market Share (2013-2018)
Table Celgene Basic Information List
Table Celgene Psoriasis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Celgene Psoriasis Drugs Sales Growth Rate (2013-2018)
Figure Celgene Psoriasis Drugs Sales Global Market Share (2013-2018)
Figure Celgene Psoriasis Drugs Revenue Global Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Psoriasis Drugs
Figure Manufacturing Process Analysis of Psoriasis Drugs
Figure Psoriasis Drugs Industrial Chain Analysis
Table Raw Materials Sources of Psoriasis Drugs Major Players in 2017
Table Major Buyers of Psoriasis Drugs
Table Distributors/Traders List
Figure Global Psoriasis Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Global Psoriasis Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Psoriasis Drugs Price (USD/Unit) and Trend Forecast (2018-2025)
Table Global Psoriasis Drugs Sales Volume (K Units) Forecast by Regions (2018-2025)
Figure Global Psoriasis Drugs Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Psoriasis Drugs Sales Volume Market Share Forecast by Regions in 2025
Table Global Psoriasis Drugs Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Psoriasis Drugs Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Psoriasis Drugs Revenue Market Share Forecast by Regions in 2025
Figure United States Psoriasis Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Psoriasis Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Psoriasis Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Europe Psoriasis Drugs Revenue and Growth Rate Forecast (2018-2025)
Figure China Psoriasis Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure China Psoriasis Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Psoriasis Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Japan Psoriasis Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Psoriasis Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Psoriasis Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Psoriasis Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure India Psoriasis Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Psoriasis Drugs Sales (K Units) Forecast by Type (2018-2025)
Figure Global Psoriasis Drugs Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Psoriasis Drugs Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Psoriasis Drugs Revenue Market Share Forecast by Type (2018-2025)
Table Global Psoriasis Drugs Price (USD/Unit) Forecast by Type (2018-2025)
Table Global Psoriasis Drugs Sales (K Units) Forecast by Application (2018-2025)
Figure Global Psoriasis Drugs Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources